Related Experiment Videos
Vessel dilator is associated with survival after acute myocardial infarction
B H Ackerman1, R P Wyeth, M E Soulsby
1Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock, USA.
Insights
Atrial natriuretic peptides, including atrial natriuretic factor, vessel dilator, and long-acting sodium stimulator, correlate with myocardial infarction size and survival in canines. Vessel dilator specifically showed a strong correlation with survival rates.
Area of Science:
- Cardiology
- Biochemistry
- Physiology
Background:
- Acute myocardial infarction (AMI) poses significant mortality risks.
- Atrial natriuretic peptides (ANPs) are implicated in cardiovascular regulation.
- Understanding ANP roles in AMI pathophysiology is crucial for prognostic assessment.
Purpose of the Study:
- To investigate the correlation between circulating ANPs and infarct size, ischemic area, and survival in a canine model of AMI.
- To identify specific ANPs that may serve as biomarkers for AMI outcomes.
Main Methods:
- Canine model of acute myocardial infarction induced by left anterior descending coronary artery occlusion.
- Measurement of circulating concentrations of atrial natriuretic factor (ANF), vessel dilator (VD), and long-acting sodium stimulator (LASS).
- Assessment of infarct size, ischemic myocardial area, and correlation with ANP levels and survival outcomes.
Main Results:
- Significant elevations in ANF, VD, and LASS were observed within 6 minutes of coronary occlusion.
- Ischemic and infarcted areas correlated significantly with circulating ANP concentrations.
- Vessel dilator emerged as the sole ANP significantly correlating with survival when analyzed via log area under the plasma concentration-time curve.
Conclusions:
- Circulating ANPs, particularly vessel dilator, are valuable indicators of infarct size and survival in acute myocardial infarction.
- Vessel dilator may serve as a potential prognostic biomarker in AMI patients.
- Further research is warranted to explore the therapeutic implications of ANPs in AMI management.
Abstract:
To assess whether infarct size, ischemic area and/or survival correlates with circulating atrial natriuretic peptides (long acting sodium stimulator, vessel dilator, or atrial natriuretic factor), these peptides were measured in a canine model of acute myocardial infarction. Elevations in the circulating concentrations of atrial natriuretic factor, vessel dilator, and long acting sodium stimulator were significant (P < 0.05) within 6 min of coronary occlusion of the left anterior descending coronary artery. The percentage of ischemic myocardium ranged from 20 to 67% with a mean of 37 +/- 17%. The area of infarction ranged from 1 to 13% with the infarcted area of non-survivors being twice that of survivors. Both the ischemic and infarcted areas correlated (P < 0.05) with the circulating concentrations of these atrial natriuretic peptides. Survival correlated also with the circulating plasma concentrations of vessel dilator, atrial natriuretic factor and long acting sodium stimulator (P < 0.05). When these circulating concentrations were evaluated, however, by determining their area under their respective concentrations curves and expressing each as the log area under plasma concentration-time curve (area under the curve) per kg of weight (Y = 58.48X-23.62; r = 0.825; P = 0.0009), vessel dilator was the only atrial natriuretic peptide that correlated with survival.